Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholestech Corp.

Division of Inverness Medical Innovations Inc./Cholestech Corp.
www.cholestech.com

Latest From Cholestech Corp.

In Vitro Diagnostics: The Quest For Growth

This article first appeared in Medtech Insight, October 2010.
Medical Device

In Vitro Diagnostics: The Quest for Growth

The global economic downturn has put pressure on large, consumer-based in vitro diagnostic markets, such as diabetes glucose-testing, driving down sales, pricing, and profits. As a result, the IVD industry is actively seeking out higher growth opportunities to offset this impact-and it is finding solutions in several areas, branching into underserved emerging markets like China and India and targeting higher-growth clinical segments such as cancer, women's health, and infectious disease. But perhaps the biggest opportunity for future growth lies in the field of molecular diagnostics, particularly products that address the move toward more personalized care. Suppliers well positioned to take advantage of this opportunity are likely to experience strong growth ahead.
Medical Device Platform Technologies

Business & Technology Briefs (11/2007)

Brief summaries of recent product and company developments in the device industry, including: poor acceptance dooms Exubera inhaled insulin; QLT bets big on ForSight plug; hot markets, lukewarm IPOs; Arteriocyte Medical launches; Synthes buys N Spine.
Medical Device

Siemens--Stealing GE's Thunder

Siemens AG continues to assemble the pieces necessary to create a one-stop-shop for medical testing. With its $7 billion take-out of Dade Behring Holdings Inc., the German industrial giant ups the acquisition ante for in vitro diagnostic companies. Rival GE may have to play catch-up if it wants to maintain its leadership position in medical testing.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Glucose Testing
    • Therapeutic Drug Monitoring
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Inverness Medical Innovations Inc.
  • Senior Management
  • Warren Pinckert II, Pres. & CEO
    John F Glenn, CFO
    Gregory L Bennett, VP, R&D
    Kenneth E Miller, VP, Sales & Mktg.
  • Contact Info
  • Cholestech Corp.
    Phone: (510) 732-7200
    3347 Investment Blvd.
    Hayward, CA 94545-3808
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register